PH27516A - Purine derivatives and use thereof in therapy - Google Patents

Purine derivatives and use thereof in therapy

Info

Publication number
PH27516A
PH27516A PH43233A PH43233A PH27516A PH 27516 A PH27516 A PH 27516A PH 43233 A PH43233 A PH 43233A PH 43233 A PH43233 A PH 43233A PH 27516 A PH27516 A PH 27516A
Authority
PH
Philippines
Prior art keywords
therapy
purine derivatives
purine
derivatives
Prior art date
Application number
PH43233A
Inventor
Roelf Datema
Bjorn Gunnar Lindborg
Karl Nils Gunnar Johannson
Bo Fredrik Oberg
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8801729A external-priority patent/SE8801729D0/en
Application filed by Medivir Ab filed Critical Medivir Ab
Priority to PH43233A priority Critical patent/PH27516A/en
Publication of PH27516A publication Critical patent/PH27516A/en

Links

PH43233A 1988-05-06 1991-10-02 Purine derivatives and use thereof in therapy PH27516A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH43233A PH27516A (en) 1988-05-06 1991-10-02 Purine derivatives and use thereof in therapy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8801729A SE8801729D0 (en) 1988-05-06 1988-05-06 PURINE DERIVATIVES FOR USE IN THERAPY
PH3862089 1989-07-05
PH43233A PH27516A (en) 1988-05-06 1991-10-02 Purine derivatives and use thereof in therapy

Publications (1)

Publication Number Publication Date
PH27516A true PH27516A (en) 1993-08-18

Family

ID=26652390

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43233A PH27516A (en) 1988-05-06 1991-10-02 Purine derivatives and use thereof in therapy

Country Status (1)

Country Link
PH (1) PH27516A (en)

Similar Documents

Publication Publication Date Title
GB2221390B (en) Niacin-containing composition and its therapeutic use
HK128693A (en) Purine derivatives and their pharmaceutical use
EP0406428A4 (en) Peptide derivatives and their use
GB2225003B (en) Improvements in and relating to activated carbons
ZA917853B (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their use in therapy
ZA885150B (en) N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy
ZA937156B (en) Piperidine derivatives their preparation and theirapplication in therapy
CY1829A (en) Adenosine derivatives their production and use
ZA922952B (en) 2-aminopyrimidine-4-carboxyamide derivatives,their preparation and their application in therapy
EP0280593A3 (en) Composition on the basis of an amino-acid and vitamins for use in cancer therapy
GB2221464B (en) Oxaza heterocycles and their use in pharmaceutical compositions
IL90000A0 (en) Benzothiazepin-4-one derivatives,their preparation and their application in therapy
IL87653A0 (en) Improvements in condoms
ZA904290B (en) 1-phenyl-1,4-dihydro-3-amino-4-oxopyridazine derivatives,their preparation and their application in therapy
GB8817497D0 (en) Improvements in lgazing
PH27516A (en) Purine derivatives and use thereof in therapy
NZ230921A (en) 3-phenyloxymethyl-cephalosporin derivatives and medicaments
AU1745092A (en) Thiazolidine derivatives and their use in therapy
GB2221239B (en) Improvements in and relating to curtain-sided trailers
HK1003571A1 (en) Alkenyltetrazole derivatives their preparation and use
GB8910262D0 (en) Immunogenic complex and its use in vaccination
ZA891263B (en) Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
IL89998A0 (en) Use of gonadoliberin derivatives in the treatment of tumours
GB8810369D0 (en) Improvements in use of solid-fuels
AU5058185A (en) Arolypyrroles and their use in immunologic therapy